Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs).
about
Molecular Imaging of Biomarkers in Breast CancerClinical practice guidelines for patients with gastrointestinal stromal tumor in TaiwanCurrent management and prognostic features for gastrointestinal stromal tumor (GIST)Validation of novel imaging methodologies for use as cancer clinical trial end-pointsAPOMAB, a La-specific monoclonal antibody, detects the apoptotic tumor response to life-prolonging and DNA-damaging chemotherapy.Absence of progression as assessed by response evaluation criteria in solid tumors predicts survival in advanced GI stromal tumors treated with imatinib mesylate: the intergroup EORTC-ISG-AGITG phase III trial.Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor.PET/CT in Oncology: Current Status and Perspectives.Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs.Initial partial response and stable disease according to RECIST indicate similar survival for chemotherapeutical patients with advanced non-small cell lung cancerTargeted therapy for cancer: the gastrointestinal stromal tumor model.Neurotensin receptor 1 is expressed in gastrointestinal stromal tumors but not in interstitial cells of Cajal.Voxelwise single-subject analysis of imaging metabolic response to therapy in neuro-oncologyNCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.Positron emission tomography molecular imaging for drug development.Molecular imaging in therapeutic efficacy assessment of targeted therapy for nonsmall cell lung cancerImaging gastrointestinal stromal tumors.Molecular imaging in oncology.Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma18F-FDG and 18F-FLT-PET imaging for monitoring everolimus effect on tumor-growth in neuroendocrine tumors: studies in human tumor xenografts in miceRethinking clinical trials for cytostatic drugs.The role of PET in monitoring therapy.Monitoring response to gefitinib in nude mouse tumor xenografts by (18)F-FDG microPET-CT: correlation between (18)F-FDG uptake and pathological response.Role of F-fluoro-2-deoxyglucose Positron Emission Tomography in Gastric GIST: Predicting Malignant Potential Pre-operatively.Molecular imaging in vivo: an introduction.Consensus report on the radiological management of patients with gastrointestinal stromal tumours (GIST): recommendations of the German GIST Imaging Working Group.(18)F-FDG PET in sarcoma treatment response imaging.Treatment with the MEK inhibitor U0126 induces decreased hyperpolarized pyruvate to lactate conversion in breast, but not prostate, cancer cells.Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatment.Time-dependent effects of imatinib in human leukaemia cells: a kinetic NMR-profiling study.[18F]fluorodeoxyglucose positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapy.A review of imaging agent development.The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate.PET imaging for Treatment Response in CancerCurrent opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo.How best to manage gastrointestinal stromal tumor.Opportunities and pitfalls of cancer imaging in clinical trials.Imaging modalities of gastrointestinal stromal tumors.US FDA draft Guidance Standard for Clinical Trial Imaging Endpoints: more than just imaging?Gastrointestinal stromal tumors: who should get imatinib and for how long?
P2860
Q26772870-6C433AA6-459C-44D8-B487-5F0B078FD0DCQ27027632-8C69A7F8-58E9-4561-8E96-E76BFF86D827Q28391684-74BA7803-E4E2-4FA5-A552-F9C1DD7ECA4AQ33394106-462104D5-38FD-41DC-BDC8-FEE15C3B4298Q33413085-CD32D258-666F-40BB-B325-CAE5ABC70DD0Q33561602-FBC16C23-5091-49DA-A3E8-7CB026D6CD13Q33654894-1C3C2C8B-8135-4CBE-9EC7-599CBBBBBC19Q33665109-C8F88317-5BA4-4F6F-98D5-266743C4FB5BQ33696408-DEB5DE0B-A4A1-4D5C-ADC8-E5DBD854037EQ33771180-17ACF3E3-1728-4E33-95F0-BE1DF55E1EB6Q33807742-5A10D414-7B80-4880-8C50-9E0D7C7AEBD8Q33833577-E7D6CB44-4C29-485B-85F9-AB33AAECCA21Q33835371-0174EC4B-C842-4CC0-A98A-C2D9B64C5FCDQ33921067-CD215BE0-4E83-4701-9EE7-DF7C1608219CQ33991881-3861C919-7433-42C3-AF84-59B16B44A666Q34243500-DF043FE3-A681-488D-8ABC-E85737605A53Q34414114-52C81EFE-A714-4AA7-9115-6949722AC138Q34533365-AA53E8B6-E33E-4163-826D-4BCCFC3A29F4Q35093281-7B6D1164-51D4-4220-8433-17C54536BBD7Q35120054-877DA358-E877-494A-BC7E-A63829C646DAQ35166825-3D3B07CD-FEDB-48F4-8EF0-555B68DE601FQ35172974-C210E06C-8063-4C0E-A634-E20CC95EEAD5Q35215449-18B08373-0ED2-4B63-9EE4-8593FB536E68Q35480804-B42E43DF-06D5-4033-B79E-AFC36FD3753EQ35968130-3C197064-DBB4-42ED-8AA1-57A2B4D39CF9Q35996655-64EFBA59-E3BB-4C74-A492-E6FC3C06EFE6Q36337223-44CD293C-8838-4B46-B5C8-79FF7E277226Q36488080-CDD1445D-E6E3-4C69-A1AE-32B5486BF8ABQ36499234-70BDC3CE-2DA4-4FB6-A1B2-5158AE6B64C3Q37141914-6378F322-6EFB-4D03-99C1-F0210498CAAFQ37210960-4C8FB7C7-B130-40F7-B450-7B0AE3807264Q37214528-45956C02-6E98-4D66-A77A-399E59A2A63DQ37252029-33895063-1905-467B-8ACB-5EA5256D5F31Q37465205-A65C6082-764B-4E19-AEC3-E898AF817FB1Q37644820-2E2E8CE1-C4CB-4C06-A2A6-4A1CB1D14B9AQ37743051-CB6647B1-3BEC-4EE4-BA07-F07C3BCB532AQ37869334-76588E84-7750-47F5-BAD4-0F8896AFC34CQ37954208-B8315865-005D-4A76-BF33-4258D3D2738BQ38066243-626DA8B0-0C0F-4886-9590-AE3FD398B157Q38257940-E10E002B-6D81-4150-8FF7-BAA8DB9CBB85
P2860
Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs).
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Use of positron emission tomog ...... stinal stromal tumors (GISTs).
@en
type
label
Use of positron emission tomog ...... stinal stromal tumors (GISTs).
@en
prefLabel
Use of positron emission tomog ...... stinal stromal tumors (GISTs).
@en
P1476
Use of positron emission tomog ...... stinal stromal tumors (GISTs).
@en
P2093
Annick D Van den Abbeele
Ramsey D Badawi
P356
10.1016/S0959-8049(02)80604-9
P478
38 Suppl 5
P577
2002-09-01T00:00:00Z